Pawhuskins: Potential Treatments for Stimulant Abuse.
Pawhuskins:兴奋剂滥用的潜在治疗方法。
基本信息
- 批准号:7842616
- 负责人:
- 金额:$ 22.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-06-01 至 2013-09-30
- 项目状态:已结题
- 来源:
- 关键词:Accident and Emergency departmentAccountingAffinityAgonistAmericanAmphetaminesAttentionAwardBehavioralBindingBinding SitesBiological FactorsBrainCategoriesCell Culture SystemChemistryCocaineDataDiseaseDrug userFundingHumanHydrogen BondingLibrariesLigandsMalignant NeoplasmsMedicalMental DepressionMethamphetamineMethyl EthersMorbidity - disease rateOpioid ReceptorOpioid Receptor BindingPenetrationPharmaceutical PreparationsPharmacotherapyPhenolsPlantsPublic HealthRelapseReplacement TherapyReportingResearch Project GrantsResveratrolSeriesStilbenesTestingTreatment outcomeUnited StatesVisitWritinganalogbasebiological adaptation to stresscareercerebrovascularchemical synthesiscomputational chemistrydelta opioid receptordesigndrug abuse preventiondrug of abusehydroxyl groupimprovedinformation gatheringkappa opioid receptorsmortalitynovelnovel therapeuticspawhuskin Apharmacophoreprogramspublic health relevancereceptorscaffoldstimulant abuse
项目摘要
DESCRIPTION (provided by applicant): Stimulant abuse (including both cocaine and amphetamines) is a serious public health problem. There are thought to be over 3 million current users of these drugs in the United States, and these drugs account for numerous emergency room visits each year. Abuse of these drugs is associated with a high rate of relapse. Despite significant unmet medical need no pharmacotherapies are currently approved for the treatment of stimulant abuse. Several programs aimed at using replacement therapy have shown some promise. Recently, there have also been reports showing kappa-opioid receptor antagonists can modulate stress responses, and stress response and depression have been shown to be important triggers for relapse. For this reason kappa-selective opioid receptor agonists and antagonists have gained some attention as potential treatments for stimulant abuse. The pawhuskins are a small set of prenylated stilbenes reported from a North American prairie plant in 2004. They were shown to have some opioid receptor modulating function in this early report. This early career award in the basic chemistry of drug abuse prevention is designed to test the hypothesis that drugs for the treatment of stimulant abuse can be derived from the pawhuskins. We propose three specific aims that are designed to test this hypothesis by systematically modifying the pawhuskin scaffold. We will first probe the requirements for hydrogen bond donors present in the natural products by blocking groups. We will then synthesize a series of analogs designed to enhance specific opioid receptor binding to improve the affinity and receptor subtype selectivity of the pawhuskin core. PUBLIC HEALTH RELEVANCE: Stimulant abuse is a major public health problem in the United States with cocaine and methamphetamine being the primary drugs of abuse in this category. Abuse of these drugs is associated with long lasting behavioral changes and propensity for relapse. Despite the morbidity and mortality associated with stimulant abuse no pharmacotherapies are currently approved for treatment of this disease. Novel therapeutics that could help with the relapse effect or otherwise improve treatment outcomes should be of high priority.
描述(由申请人提供):兴奋剂滥用(包括可卡因和安非他明)是一个严重的公共卫生问题。据认为,在美国,目前有超过300万人使用这些药物,这些药物每年都有许多急诊室就诊。滥用这些药物与高复发率有关。尽管存在显著的未满足的医疗需求,但目前尚无药物疗法被批准用于治疗兴奋剂滥用。几个旨在使用替代疗法的项目已经显示出一些希望。最近,也有报道显示κ-阿片受体拮抗剂可以调节应激反应,应激反应和抑郁已被证明是复发的重要触发因素。由于这个原因,κ-选择性阿片受体激动剂和拮抗剂作为兴奋剂滥用的潜在治疗方法获得了一些关注。Pawhuskin是2004年从北美草原植物中报道的一小组异戊二烯化芪。在这一早期报道中,它们被证明具有一些阿片受体调节功能。这个早期职业奖在药物滥用预防的基础化学的目的是测试的假设,用于治疗兴奋剂滥用的药物可以从pawhuskins。我们提出了三个具体的目标,旨在通过系统地修改pawhuskin支架来验证这一假设。我们将首先探讨天然产物中存在的氢键供体的封闭基团的要求。然后,我们将合成一系列旨在增强特异性阿片受体结合的类似物,以提高木瓜蛋白酶核心的亲和力和受体亚型选择性。公共卫生关系:兴奋剂滥用是美国的一个主要公共卫生问题,可卡因和甲基苯丙胺是这类滥用的主要药物。这些药物的滥用与长期持续的行为变化和复发倾向有关。尽管与兴奋剂滥用相关的发病率和死亡率,但目前尚无药物治疗被批准用于治疗这种疾病。可以帮助复发效应或以其他方式改善治疗结果的新疗法应该是高度优先的。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Direct conversion of benzylic and allylic alcohols to phosphonates.
- DOI:10.1021/jo200137k
- 发表时间:2011-04-15
- 期刊:
- 影响因子:3.6
- 作者:Barney, Rocky J.;Richardson, Rebekah M.;Wiemer, David F.
- 通讯作者:Wiemer, David F.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEFFREY D NEIGHBORS其他文献
JEFFREY D NEIGHBORS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEFFREY D NEIGHBORS', 18)}}的其他基金
Feasibility study of GGDPS inhibition for osteoporosis
GGDPS抑制骨质疏松症的可行性研究
- 批准号:
8522844 - 财政年份:2013
- 资助金额:
$ 22.03万 - 项目类别:
Schweinfurthins: novel treatment for breast cancer
Schweinfurthins:乳腺癌的新疗法
- 批准号:
7798657 - 财政年份:2010
- 资助金额:
$ 22.03万 - 项目类别:
Pawhuskins: Potential Treatments for Stimulant Abuse.
Pawhuskins:兴奋剂滥用的潜在治疗方法。
- 批准号:
7638987 - 财政年份:2009
- 资助金额:
$ 22.03万 - 项目类别:
Improving the Distribution of Geranylgeranyl Diphosphate synthase inhibitors.
改善香叶基香叶基二磷酸合酶抑制剂的分布。
- 批准号:
7608986 - 财政年份:2009
- 资助金额:
$ 22.03万 - 项目类别:
Preclinical Development of Geranylgeranyl Disphosphate Synthase Inhibitors as Ant
香叶基香叶基二磷酸合酶抑制剂 Ant 的临床前开发
- 批准号:
7325831 - 财政年份:2007
- 资助金额:
$ 22.03万 - 项目类别:
Developing Schweinfurthin Analogs as Glioma Therapies
开发 Schweinfurthin 类似物作为神经胶质瘤疗法
- 批准号:
8055678 - 财政年份:2007
- 资助金额:
$ 22.03万 - 项目类别:
Developing Schweinfurthin Analogs as Glioma Therapies
开发 Schweinfurthin 类似物作为神经胶质瘤疗法
- 批准号:
7668303 - 财政年份:2007
- 资助金额:
$ 22.03万 - 项目类别:
相似海外基金
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 22.03万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
- 批准号:
10100360 - 财政年份:2024
- 资助金额:
$ 22.03万 - 项目类别:
Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
- 批准号:
24K04974 - 财政年份:2024
- 资助金额:
$ 22.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
- 批准号:
23K01686 - 财政年份:2023
- 资助金额:
$ 22.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
- 批准号:
23K01692 - 财政年份:2023
- 资助金额:
$ 22.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
- 批准号:
23K01695 - 财政年份:2023
- 资助金额:
$ 22.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
- 批准号:
23K01713 - 财政年份:2023
- 资助金额:
$ 22.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
- 批准号:
2312319 - 财政年份:2023
- 资助金额:
$ 22.03万 - 项目类别:
Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
- 批准号:
23K01715 - 财政年份:2023
- 资助金额:
$ 22.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
- 批准号:
10585388 - 财政年份:2023
- 资助金额:
$ 22.03万 - 项目类别:














{{item.name}}会员




